Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-16

Clinical Trial Update: Bee Venom for the Treatment of Parkinson Disease [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial investigating bee venom as a treatment for Parkinson disease, with the study now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bee venom (Apis mellifera venom)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED